Paychex Forecast, price target & analysts
Paychex Target price 2025 - Analyst rating & recommendation
Paychex Classifications & Recommendation:
Paychex Price Target
| Target Price | $153.51 |
| Price | $140.81 |
| Potential | 9.02% |
| Number of Estimates | 16 |
| 16 Analysts have issued a price target Paychex 2026 . The average Paychex target price is $153.51. This is 9.02% higher than the current stock price. The highest price target is $173.25 23.04% , the lowest is $125.83 10.64% . | |
| A rating was issued by 22 analysts: 1 Analysts recommend Paychex to buy, 16 to hold and 5 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Paychex stock has an average upside potential 2026 of 9.02% . Most analysts recommend the Paychex stock at Hold. |
Sales and Margin forecast 2026, 2027 & 2028
18 Analysts have issued a sales forecast Paychex 2026 . The average Paychex sales estimate is $6.7b . This is 19.77% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $6.9b 24.59% , the lowest is $6.4b 14.18% .
This results in the following potential growth metrics:
Revenue Estimates
| 2025 | $5.6b | 5.56% |
|---|---|---|
| 2026 | $6.7b | 19.77% |
| 2027 | $7.1b | 6.52% |
| 2028 | $7.4b | 4.42% |
12 Analysts have issued an Paychex EBITDA forecast 2026. The average Paychex EBITDA estimate is $3.1b . This is 23.44% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $3.4b 35.54% , the lowest is $2.9b 13.24% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2025 | $2.4b | 1.25% |
|---|---|---|
| 2026 | $3.1b | 29.50% |
| 2027 | $3.4b | 8.26% |
| 2028 | $3.5b | 4.24% |
EBITDA Margin
| 2025 | 43.43% | 4.08% |
|---|---|---|
| 2026 | 46.97% | 8.14% |
| 2027 | 47.73% | 1.62% |
| 2028 | 47.66% | 0.15% |
19 Paychex Analysts have issued a net profit forecast 2026. The average Paychex net profit estimate is $2.0b . This is 21.04% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.1b 25.39% , the lowest is $1.9b 15.97% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2025 | $1.7b | 1.96% |
|---|---|---|
| 2026 | $2.0b | 21.04% |
| 2027 | $2.2b | 7.92% |
| 2028 | $2.3b | 8.37% |
Net Margin
| 2025 | 29.74% | 7.12% |
|---|---|---|
| 2026 | 30.06% | 1.06% |
| 2027 | 30.46% | 1.33% |
| 2028 | 31.61% | 3.78% |
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
19 Analysts have issued a Paychex forecast for earnings per share. The average Paychex EPS is $5.56 . This is 21.66% higher than earnings per share in the financial year 2025. The highest EPS forecast is $5.76 26.04% , the lowest is $5.33 16.63% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2025 | $4.58 | 1.93% |
|---|---|---|
| 2026 | $5.56 | 21.40% |
| 2027 | $6.01 | 8.09% |
| 2028 | $6.51 | 8.32% |
P/E ratio
| Current | 30.29 | 12.97% |
|---|---|---|
| 2026 | 24.87 | 17.88% |
| 2027 | 23.05 | 7.32% |
| 2028 | 21.27 | 7.72% |
Based on analysts' sales estimates for 2026, the Paychex stock is valued at an EV/Sales of 7.97 and an P/S ratio of 7.47 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 9.54 | 13.57% |
|---|---|---|
| 2026 | 7.97 | 16.49% |
| 2027 | 7.48 | 6.12% |
| 2028 | 7.16 | 4.23% |
P/S ratio
| Current | 8.95 | 4.88% |
|---|---|---|
| 2026 | 7.47 | 16.50% |
| 2027 | 7.01 | 6.12% |
| 2028 | 6.72 | 4.23% |
Current Paychex Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Underweight
➜
Underweight
|
Unchanged | Aug 14 2025 |
| BMO Capital |
➜
Market Perform
|
Initiated | Jul 10 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jun 27 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Jun 26 2025 |
| Stifel |
Hold
➜
Hold
|
Unchanged | Jun 26 2025 |
| Jefferies |
Hold
➜
Hold
|
Unchanged | Jun 26 2025 |
| JP Morgan |
Underweight
➜
Underweight
|
Unchanged | Jun 18 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
JP Morgan:
Underweight
➜
Underweight
|
Aug 14 2025 |
|
Initiated
BMO Capital:
➜
Market Perform
|
Jul 10 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Jun 27 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Jun 26 2025 |
|
Unchanged
Stifel:
Hold
➜
Hold
|
Jun 26 2025 |
|
Unchanged
Jefferies:
Hold
➜
Hold
|
Jun 26 2025 |
|
Unchanged
JP Morgan:
Underweight
➜
Underweight
|
Jun 18 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
